Shanghai, China

Youxin Wang

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Youxin Wang: Innovator in Pharmaceutical Compounds

Introduction

Youxin Wang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptor proteins. His work has implications for the treatment of various diseases, showcasing his innovative approach to drug development.

Latest Patents

Youxin Wang holds a patent for a compound titled "3-aryloxyl-3-five-membered heteroaryl propylamine compound and use thereof." This patent discloses a compound or a pharmacologically acceptable salt or prodrug thereof. The compound exhibits excellent inhibition of transient receptor potential (TPR) channel proteins, demonstrating a promising therapeutic effect on diseases associated with these proteins. He has 1 patent to his name.

Career Highlights

Throughout his career, Youxin Wang has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Shanghai Leado Pharmatech Co. Ltd. and Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Youxin Wang has collaborated with several professionals in his field, including Lingling Zhang and Jinxia Lin. These collaborations have likely enhanced his research and development efforts, leading to advancements in pharmaceutical compounds.

Conclusion

Youxin Wang is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of various diseases. His innovative contributions and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…